GENENET TECHNOLOGY (UK) LIMITEDActive
Key figures
Like most small UK companies, GENENET TECHNOLOGY (UK) LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2021/22–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | — | 2,278 | 477 | 5,863 |
| Total assets | 20,438 | 25,332 | 17,996 | — | 17,913 |
| Total liabilities | 26,532 | 123,257 | 178,413 | — | 375,459 |
| Net assets / total equity | 6,094 | 97,925 | -160,417 | -288,991 | -357,546 |
| Average number of employees | 2 | 9 | 5 | 4 | 3 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: GENENET TECHNOLOGY (UK) LIMITED
Company
GENENET TECHNOLOGY (UK) LIMITED is a private limited company registered with Companies House under company number 13145388. It was incorporated on 20 Jan 2021. Its status is active. The registered office is in London (EC1V). Its nature of business (SIC 2007) is engineering design activities for industrial process and production (71121), engineering related scientific and technical consulting activities (71122), technical testing and analysis (71200), research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025/26 (period ending 5 Apr 2026); the company files abridged accounts (unaudited). Net assets were −£357,546, down 23.7% on the previous year. Cash at bank and in hand was £5,863. Total assets were £17,913 and total liabilities £375,459. The company had an average of 3 employees. Figures are available for 5 financial years (2021/22–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 5 Jan 2028. The next confirmation statement is due by 2 Feb 2027.